Revolution Medicines Inc (RVMD)
56.75
-0.03
(-0.05%)
USD |
NASDAQ |
Nov 22, 16:00
58.96
+2.21
(+3.89%)
After-Hours: 20:00
Revolution Medicines Enterprise Value: 7.997B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 7.997B |
| November 21, 2024 | 8.002B |
| November 20, 2024 | 8.051B |
| November 19, 2024 | 7.950B |
| November 18, 2024 | 7.575B |
| November 15, 2024 | 7.724B |
| November 14, 2024 | 8.101B |
| November 13, 2024 | 8.229B |
| November 12, 2024 | 8.431B |
| November 11, 2024 | 8.645B |
| November 08, 2024 | 8.618B |
| November 07, 2024 | 8.392B |
| November 06, 2024 | 8.446B |
| November 05, 2024 | 7.997B |
| November 04, 2024 | 7.849B |
| November 01, 2024 | 7.692B |
| October 31, 2024 | 7.425B |
| October 30, 2024 | 6.922B |
| October 29, 2024 | 6.908B |
| October 28, 2024 | 6.461B |
| October 25, 2024 | 6.237B |
| October 24, 2024 | 6.377B |
| October 23, 2024 | 6.588B |
| October 22, 2024 | 6.356B |
| October 21, 2024 | 6.461B |
| Date | Value |
|---|---|
| October 18, 2024 | 6.910B |
| October 17, 2024 | 6.838B |
| October 16, 2024 | 6.908B |
| October 15, 2024 | 6.669B |
| October 14, 2024 | 6.707B |
| October 11, 2024 | 6.918B |
| October 10, 2024 | 6.754B |
| October 09, 2024 | 6.752B |
| October 08, 2024 | 6.799B |
| October 07, 2024 | 6.392B |
| October 04, 2024 | 6.388B |
| October 03, 2024 | 6.189B |
| October 02, 2024 | 6.164B |
| October 01, 2024 | 6.028B |
| September 30, 2024 | 6.058B |
| September 27, 2024 | 5.787B |
| September 26, 2024 | 5.736B |
| September 25, 2024 | 5.903B |
| September 24, 2024 | 5.826B |
| September 23, 2024 | 5.530B |
| September 20, 2024 | 5.996B |
| September 19, 2024 | 6.123B |
| September 18, 2024 | 5.769B |
| September 17, 2024 | 5.721B |
| September 16, 2024 | 5.849B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
560.77M
Minimum
May 12 2022
8.645B
Maximum
Nov 11 2024
2.306B
Average
1.745B
Median
Sep 24 2020
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -31.63M |
| Electromed Inc | 238.10M |
| Xtant Medical Holdings Inc | 83.10M |
| Myomo Inc | 147.33M |
| Catheter Precision Inc | 3.859M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -156.29M |
| Total Expenses (Quarterly) | 175.71M |
| EPS Diluted (Quarterly) | -0.94 |
| Earnings Yield | -6.45% |
| Normalized Earnings Yield | -6.766 |